Leslie Walker

Generic drugs gave Americans access to effective, cheap prescription medications. It’s saved them trillions of dollars over the past few decades. But there are signs this vital industry may be in deep trouble.

America’s health care leaders have spent two decades searching for a way to keep costly, complicated patients from cycling in and out of the hospital dozens of times a year. What have they learned?

Through a combination of holistic care and house calls, doctor Clarissa Kripke is redefining what health care can be and do for adults with conditions like Down syndrome and cerebral palsy.

A new bipartisan bill takes aim at a $500 billion government health care mess. Will it make care better for some of the country’s sickest, poorest patients?

New regulations designed to crack down on misleading marketing of Medicare insurance plans face their first big test when seniors begin shopping for coverage on Oct. 15.

A bipartisan group of lawmakers agree: Medicare and Medicaid are failing 12 million of the country's most vulnerable patients.

For the first time in its 58-year history, Medicare, the public health insurance program for seniors, will have the power to ask for price cuts from drugmakers thanks to the Inflation Reduction Act passed last year.

What’s a fair price to pay for prescription drugs? Medicare will soon face this and other tough questions when it begins historic price negotiations with drugmakers.

The rapid growth of private Medicare Advantage plans is raising questions about what care could — and should — look like for all 80 million people expected to be on Medicare by 2030.

Congress is considering legislation that would cut the prices Medicare pays hospitals for some common outpatient services like X-rays, injections and check-ups.